ஒளி டெலிவரி அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஒளி டெலிவரி அமைப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஒளி டெலிவரி அமைப்பு Today - Breaking & Trending Today

LumiThera Completes Patient Enrollment in the U.S. Multi-Center, LIGHTSITE III Clinical Study to Treat Dry Age-Related Macular Degeneration


Published: Feb 10, 2021
 
SEATTLE, Feb 10, 2021 /PRNewswire/ LumiThera, Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed enrollment in its multi-center United States clinical study in non-neovascular (dry) Age-Related Macular Degeneration (AMD) patients.
The randomized, multi-center study, LIGHTSITE III, enrolled the last patient at the Byers Eye Institute at Stanford University in Palo Alto, CA with Principal Investigator, Diana Do, M.D.  We are very pleased to be able to enroll the last subject in the Study!  Initial efficacy data will be available in approximately 13 months, indicated Dr. Do.  The study will continue to follow patients for up to 24 months. ....

United States , Rene Ruckert , Clark Tedford , National Eye Institute , National Institute Of Health , European Union , Food Drug Administration , Prnewswire Lumithera Inc , Lumithera Inc , Age Related Macular Degeneration , Byers Eye Institute , Stanford University , Palo Alto , Principal Investigator , Light Delivery System , National Institute , Cumberland Valley Retina , Valeda Light Delivery System , Chief Medical , Cindy Croissant , Vice President , Drug Administration , Lumithera Completes Patient Enrollment In The Us Multi Center , Lightsite Iii Clinical Study To Treat Dry Age Related Macular Degeneration , ஒன்றுபட்டது மாநிலங்களில் , ரெனே றுக்கேர்ட் ,